AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am an Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
Curiosity line teal background

ASIC v FIIG Securities – AFSL Holders on Notice for Cyber Failures

Apr 16 2025

Read More
Curiosity line pink background

Update – Court approves $8.25 million penalty and orders costs against Clorox for greenwashing marketing practices

Apr 15 2025

Read More
featured image

German coalition agreement: What impact will the future German Federal Government's security initiatives have on telecommunications companies?

4 minutes Apr 14 2025

Read More